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Background: Germinated brown rice (GBR) is gaining momentum in the area of biomedical research due to its
increased use as a nutraceutical for the management of diseases. The effect of GBR on the reproductive organs of
oophorectomised rats was studied using the gross, cytological, histological and immunohistochemical changes,
with the aim of reducing atrophy and dryness of the genital organs in menopause.
Methods: Experimental rats were divided into eight groups of six rats per group. Groups 1, 2 and 3 (sham-operated
(SH), oophorectomised without treatment (OVX) and oophorectomised treated with 0.2 mg/kg oestrogen,
respectively) served as the controls. The groups 4,5,6,7 and 8 were treated with 20 mg/kg Remifemin, 200 mg/kg of
GBR, ASG, oryzanol and GABA, respectively. All treatments were administered orally, once daily for 8 weeks. Vaginal
smear cytology was done at the 7th week on all the rats. The weight and dimensions of the uterus and vagina
were determined after sacrifice of the rats. Uterine and vaginal tissues were taken for histology and
Immunohistochemical examinations.
Results: GBR and its bioactives treated groups significantly increased the weight and length of both the uterus and
the vagina when compared to Oophorectomised non-treated group (OVX-non-treated) (p < 0.05). Significant
changes were observed in the ratio of cornified epithelial cells and number of leucocytes in the vaginal cytology
between the oophorectomised non-treated and treated groups. There was also an increase in the luminal and
glandular epithelial cells activity in the treated compared with the untreated groups histologically.
Immunohistochemical staining showed specific proliferating cell nuclear antigen (PCNA) in the luminal and
glandular epithelium of the treated groups, which was absent in the OVX-non-treated group. GBR improved the
length and weight of the uterus and also increased the number of glandular and luminal cells epithelia of
the vagina.
Conclusion: GBR and its bioactives could be a potential alternative in improving reproductive system atrophy,
dryness and discomfort during menopause.
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The shifting trend in the management of ailments from
synthetic compounds and drugs to nutraceutical and na-
tural products has gained momentum in the last two
decades. In this respect, germinated brown rice (GBR)
and it bioactive compounds have been among the most
widely studied, especially in the area of metabolic dis-
eases such as obesity, cancer and diabetes [1-4]. GBR is
brown rice that is soaked for 12-24 hours at varying
temperature, during which it sporulates and releases its
bioactive nutrients, which increase in quantity to ap-
proximately twice its original content. Some of the nutri-
ents reported to increase include γ-amino butyric acid
(GABA), dietary fibre, inositol, ferulic acid, phytic acid,
tocotrinols, magnesium, potassium, zinc, γ-oryzanol and
prolylendopeptidase inhibitor [5]. It has been reported
that GABA increased dramatically when brown rice was
soaked at 40°C in water for 8–24 hours [6]. Documented
effectiveness of GBR also includes suppression of liver
damage, hypercholesterolaemia and neuro-protective ef-
fects [7-9].
Menopause is a natural transition in a woman’s life in
which her menstrual cycle ceases and she is no longer
fertile due to depletion of ovarian follicles and a gradual
decrease in ovarian production of oestrogen and other
hormones [10] The decrease in oestrogen level during
the menopause is associated with atrophy of the genital
organs whereby the mucosa becomes inelastic, pale, dry
and thin. Vaginal atrophy leads to dyspareunia, thus
impairing sexual functioning, which invariably leads to
psychological stress. There is also increased suscepti-
bility to infection, trauma and urinary incontinence [11]
Although conventional hormone therapy is highly ef-
fective in suppressing menopausal disorders, there is
widespread concern about its safety. Previous studies re-
ported the effects of late complications due to hormone-
replacement therapy (HRT) such as breast, uterine and
ovarian cancers, vaginal bloating and bleeding, and car-
diovascular and other related complications [12-17].
Soy isoflavones have been established to have a selec-
tive oestrogenic effect and recent studies implicated ge-
nistein, a component of soy, in the enhancement of
chemically induced colon and breast cancers [18-20].
Vaginal cytology of female rats can be used to deter-
mine the oestrous cycle, hormonal status and the relative
function of the reproductive system in rats. The stages
of the vaginal cell cycle correlate well with the changes
in the ovaries and uterus. Also, the proportion and dis-
tribution of the various types of cells in the vaginal
smear determines the healthy state of the reproductive
system and the hormonal level. Proliferating cell nuclear
antigen (PCNA) is as an endogenous marker for cell
proliferation and has been equated to the Brdu prolifera-
tion assay [21-24]. It acts as a docking site for a numberof proteins involved in the regulation of cell cycle and
DNA repair [24,25]. An organ such as the uterus, which
is always under the influence of ovarian hormones,
serves as a good model for PCNA evaluation in prolife-
ration [21].
The gross and histological appearances of tissues are
important parameters in accessing the effect of adminis-
tered compounds in both pharmacological and toxico-
logical studies. The aim of this study is to ascertain the
possibility of using germinated brown rice as a substitute




Forty-eight mature Sprague–Dawley rats of 12 weeks
of age, weighing 250–260g were procured from the
Faculty of Veterinary Medicine University Putra Malaysia
(Serdang, Selangor, Malaysia). They were acclimatised for
2 weeks and given feed and water adlibitum. The whole
animal study was done at the animal house, Faculty of
Medicine and Health Science, University Putra Malaysia
where the rats were housed in plastic cages in a controlled
air-conditioned room (25–30°C) with exposure to 12/12-h
light/dark cycle. The study was carried out according to
the guidelines for the use of animals and was approved by
the Animal Care and Use Committee (ACUC) of the Fac-
ulty of Medicine with approval number UPM/FPSK/
PADS/UUH/F01. After acclimatisation, the rats were
grouped into eight groups of six rats each.
GBR, drugs and chemicals
Brown rice was from Bernas Rice company (Malaysia),
Cimicifuga racemosa (Remifemin® 20 mg/tab) was pur-
chased from Schaper & Brummer GmbH&Co. (Salzgitter,
Germany). Conjugated oestrogen (Premarin® 0.625 mg/tab)
was procured from Wyeth Ireland Newbridge, (Co. Kildare,
Ireland). Xylazine HCL 20 mg/ml and ketamine HCL were
from TROY laboratories PTY Ltd (Smithfield, Australia).
Extract and drug preparation
Brown rice phenolics were extracted using 80% me-
thanol and analysed by HPLC as earlier reported [26],
GABA was extracted from GBR and subsequently ana-
lysed using HPLC-DAD (Agilent, Santa Clara, CA) [27],
oryzanol was analysed using the method reported by
Azlan [28] and ASG was extracted using a combination
of methanol and chloroform and quantified using GCMS
[29].The four different samples were dissolved in dis-
tilled water (100 mg/5mls) using (0.2%) tween 20, ho-
mogenised with a high-speed homogeniser and a final
effective dose of 200 mg/kg/day was administered orally.
Premarin(0.625 mg/tablet)was ground into powder
using a blender and dissolved in distilled water (17.5 mg
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final dose of 0.2 mg/kg/day was administered orally [30].
Remifemin (20 mg/tablet) were ground into powder
using an electric blender, dissolved in distilled water at a
concentration of 1 mg/ml, and a final dose of 20 mg/kg/day
was administered orally.
Surgical procedure
The group 1rats were sham operated by exposing the
ovaries and returning them back to their anatomical
position. Bilateral oophorectomy was performed on all
the rats in groups 2-8under anaesthesia using 12 mg/
80 mg/kg xylazine/ketamine. The dorso-lateral part of
the abdominal region was scrubbed and shaved, disin-
fected with poviden-iodine using gauze bandage. Two
incisions of 1 cm long were performed on each of the
caudal parts of the dorso-lateral area of the rats using
sharp scissors after lifting the skin with a tom-forceps.
Muscles were separated along their fibres and ovaries
were located, double ligated and removed. The wound
was then closed in two layers.
Grouping and dosing
Two weeks after the surgery, treatment for the study
was commenced on the rats. The group 2 rats were
oophorectomised without treatment; groups 3 and 4
were treated with 0.2 mg/kg oestrogen and 20 mg/kg
Remifemin, respectively, while groups 5, 6, 7 and 8 were
treated with GBR, ASG, GABA and oryzanol at the dose
rate of 200 mg/kg, respectively. All treatments were ad-
ministered orally once a day for 8 weeks.
Vaginal cytology
At the seventh week, vaginal smears were taken from
each rat in the groups at approximately the same time of
the day between 8 am-10 am over a period of four days,
to minimise the incidence of transitional and missed
stages. Lavage with saline (0.9% NaCl) was done by flu-
shing the cells from the vaginal lining by introducing
0.2mls of normal saline into the vagina using a pipette
and gently aspirating the content. This releasing and as-
pirating is done 2–3 times, then one or two drops of the
resulting cell suspension is placed on a clean slide and
covered with a slip and then mounted on a light micro-
scope for viewing.
Sacrifice, tissue sectioning and histology
At the eighth week, all the rats were sacrificed un-
der ether anaesthesia, the uterus gently removed and the
length and weight recorded immediately. They were
then transferred immediately into RCL2 and stored
at -80°C until analysis. The samples were later fixed in
10% formalin for 24 hours, sectioned and stained usingHaematoxylin and Eosin (H&E) stain and observed un-
der a light microscope.
Immuno-peroxidase
Immunohistochemistry to detect the presence of PCNA
was done following the same procedure reported earlier
[31] with some modifications. Sections were mounted
on gelatin-coated glass slides, deparaffinised in three
changes of xylol and rehydrated in graded alcohol then
washed with distilled water. The sections were then
placed in 10 mmol citrate buffer, pH 6.0, for 10 mins at
50 W in a microwave, cooled at room temperature for
5 minutes. Non-specific bindings were covered using 5%
bovine serum albumin (BSA), Sections were then incu-
bated using H2O2 (3%) for 30 minutes to block endogen-
ous peroxidase activity and washed in PBST and distilled
water. PC10 monoclonal antibody procured from
DakoCytomation (Denmark) was used as the primary
antibody for an hour at a ratio of 1:200 then rinsed in
PBS and reacted with polyclonal rabbit anti-mouse as
the secondary antibody for 10 minutes at room tem-
perature. The peroxidase reactions were developed in
3,3-diaminobenzidine in chromagen solution (DAB +
CHROMAGEN) and counter stained with methylene
blue for 2 minutes, and finally, sections were cleared in
xylene and cover-slipped for examination under a light
microscope.
Statistical analysis
All samples were analysed in triplicate. Data were pre-
sented as mean ± standard deviation (SD). Differences
were evaluated by one-way analysis of variance (ANOVA)
and mean comparison was determined by Turkey Kramer
LST, using JMP10 statistical software. Differences were
considered significant at p < 0.05.
Results
Uterine weight and length
Grossly, the uteri of the oophorectomised non-treated
control rats were atrophied compared to the sham-
operated control and the oophorectomised treated rats
as shown in Table 1. Significant differences were ob-
served in the weight and length of the uterus and vagina
of the oophorectomised treated group, the oophorecto-
mised non-treated and the group treated with Remifemin
(p < 0.0001). The significance levels between the groups
were indicated in Table 1.
Vaginal cytology
The vaginal cells (cornified and epithelial) increased in
number in oophorectomised treated rats at the 7th week
of treatment compared to the oophorectomised non-
treated group (Table 2 and Figure 1).
Table 1 Mean ± SD uterus and vaginal weight and length after 8 weeks of intervention with GBR and its bioactives in
oophorectomised rats












Uterus weight(g) 0.91 ± 0.18b 0.41 ± 0.08c 1.31 ± 0.32a 0.56 ± 0.05c 0.85 ± 0.04b 0.88 ± 0.07b 0.89 ± 0.06b 0.87 ± 0.04b
Uterus length (cm) 5.05 ± 0.39a 3.21 ± 0.41b 5.85 ± 0.89 a 3.99 ± 0.31b 5.06 ± 0.44 a 5.21 ± 0.40 a 5.14 ± 0.35 a 5.06 ± 0.29 a
Vaginal weight(g) 0.19 ± 0.05a 0.06 ± 0.01b 0.17 ± 0.04a 0.05 ± 0.01b 0.18 ± 0.06a 0.18 ± 0.06a 0.19 ± 0.04a 0.17 ± 0.04a
Vaginal length (cm) 0.94 ± 0.08a 0.27 ± 0.06b 0.89 ± 0.08a 0.33 ± 0.03b 0.94 ± 0.04a 0.93 ± 0.04a 0.91 ± 0.05a 0.90 ± 0.07a
Means Comparisons for all pairs using Tukey-Kramer HSD (values with different superscripts a, b, c in the same row are significantly different p < 0.0001).
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Histologically, the sham-operated non-treated group
showed normal uterine activity, while the oophorecto-
mised non-treated group showed depleted epithelia with
slight to absent uterine activity(Figure 2A and B). The
oestrogen-treated group had an increased number of
glands and epithelial lining, the group treated with ASG
at 200 mg showed an increased number of glands, while
the epithelia lining was slightly depleted (Figure 2C
and D). The uteri of 200mgGBR-treated rats showed in-
creased glandular formation containing fluid that showed
activity and the γ-oryzanol-treated group(ORZ 200 mg)
exhibited an increase in proliferation of uterine glands,
which were very active (Figure 2F and H). Remifemin
(20 mg) showed an increase in the number of the uterine
glands and empty lumens with increased epithelial lining,
The group treated with the GABA fraction (200 mg)
showed an increase in uterine glands, and slight epithelial
depletion (Figure 2G and E).
Immunohistochemistry
Immunoreactivity for PCNA was observed in the lu-
minal and glandular epithelium, as well as the stromal
cells, which was observed in positive control sections
and also in treated groups. Positive cells exhibited a
dark-brown homogeneous staining, while the light-brown
staining areas showed less reactivity. Sham-operated rats
as well as oestrogen-, oryzanol- and Remifemin-treated
groups all showed PCNA reaction on stromal and luminal
epithelial linings as shown in Figures 3A, C, G and H.
Groups treated with ASG, GBR and GABA showed PCNA
reaction on stromal, luminal and glandular epithelial
cells, with the group treated with GABA showing strongTable 2 Proportions of vaginal cell count at the 7th week afte
brown rice and its bioactives
Groups
cell type




Cornified cells + - ++ ++
Epithelial cells +++ + +++ ++
Leucocytes + +++ + +
Key: +++ = high, ++ =moderate, + = low, - = absent.
EST Estrogen.
REM Remifemin.reactivity as shown in Figures 3D, E and F. Oophorecto-
mised non-treated rats showed a mild PCNA reaction
only on the columnar epithelial lining (Figure 3B).
Discussion
The use of natural substances as hormonal-replacement
therapy in menopause is well documented in the litera-
ture though the availability and safety margin is a source
of concern. In this study, germinated brown rice and its
bioactives after eight weeks of oral treatment grossly
restored the weight and length of atrophied uteri and va-
gina of rats compared to those of oophorectomised non-
treated control group. A significant increase in both the
weight and length of the uterus and the vagina was ob-
served when comparing the sham-operated with the
oophorectomised non-treated groups, and the groups
treated with GBR, ASG, oryzanol, GABA and oestrogen
with the group treated with Remifemin(p < 0.0001). Si-
milar effects were observed on uterine weight between
oophorectomised and non-oophorectomised rats treated
with Daidzine, Genistein, oestradiol or honey [32-34].
There are observable differences on the vaginal cytology
between the various treatment groups compared with
the oophorectomised non-treated rats, including the ra-
tio of distribution between the three cells. Cornified cell
were observed in high number in the group treated with
GABA fractions, the epithelial cells were observed in
higher number in groups treated with oestrogen, ory-
zanol and ASG, while the group treated with GBR had
almost an equal number of the two cells. Oestrous cycle
is a rhythmic reproductive cycle that is influenced by the
release of gonadotropin-releasing hormone from the









+ + + +++
+ +++ +++ +
+ + + +
Figure 1 Unstained vaginal smears (cytology) of the female rats at the 7th week after ovariectomy. The diagram shows various stages of
the oestrous cycle depending on the average of the dominating cells after four days of consecutive sampling in various treatment groups.
(E = Epithelial cells, C = Cornified cells, L = Leucocytes). (A) Sham operated (No OVX), (B) OVX (No treatment), (C) oestrogen treated (OVX + EST),
(D) ASG fraction (OVX + ASG), (E) GABA fraction (OVX + GABA), (F) GBR fraction (OVX + GBR), (G) Remifemin treated (OVX + REM), (H) (OVX + Oryzanol).
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number of vaginal cells at a particular time of the oes-
trous cycle gives a clear picture of the functional status
of the neuro-endocrine – reproductive system and ovar-
ian activity [36]. Therefore, the high number of cornified
as well as epithelial cells observed after treating the rats
with GBR and its bioactives indicate the effects of these
compounds in restoring the neuro-endocrine reproduc-
tive and ovarian function already lost due to oopho-
rectomy. These changes observed on vaginal cytology
and gross modification may be an indication that GBR
and its bioactives possess oestrogenic activity, and
Remifemin has little or no effect on the uterine tissue as
earlier reported [37]. Histologically, rat uteri treated with
GBR and its bioactives showed increased activity of the
uterine cells and also the glands. PCNA, which is an in-
dicator of DNA synthesis as well as cell proliferation,
showed positive reactions on the treated cells and this
showed that the cells are on their early propagation and
duplication at the synthetic (S) phase cycle as reported
by other workers [38,39]. Thus, the cells of the treated
groups were in the early stages of duplication and
showed strongly positive nuclear reactivity. The PCNAreaction also correlated well with the stages of oestrous
cycle in this study and this finding is comparable with
an earlier study [21]. It has been reported that mitosis
usually increased from dioestrus toward proestrus, while
cell death and apoptosis was low at this stage, and high
towards oestrous, and the observation is related to the
concentration of ovarian steroid hormones that increases
at dioestrus and proestrous and decreases towards
oestrous [40,41]. In this study, we observed that our
sham- and oophorectomy-treated rats hada higher aver-
age number of cornified and epithelial cells than the
oophorectomised non-treated groups, which showed
that the GBR- and its bioactive compound-treated oopho-
rectomised rats were mostly at their pro- or dioestrous
stage of the oestrous cycle. A positive light-brown stai-
ning immunoreactivity was observed in the control sham
groupand ASG- and oryzanol-treated groups at both the
stroma, glandular and luminal epithelium –this clearly in-
dicated that the induction of proliferation by these com-
pounds was controlled and minimal. Previous studies have
shown that GBR contains a lot of bioactives that have
antioxidant [26,42], anti-colon cancer [43], anti-diabetic
[29,44-46] and other numerous effects, ASG, for instance,
Figure 2 Histological sections of oophorectomised rats uteri treated with the different fractions of the compounds for 8 weeks
(H&E STAIN) ×100. E = Epithelial cells; G = Glandular cells. (A) Sham operated (No OVX), (B) OVX (No treatment), (C) oestrogen treated
(OVX + EST), (D) ASG fraction (OVX + ASG), (E) GABA fraction (OVX + GABA), (F) GBR fraction (OVX + GBR), (G) Remifemin treated (OVX + REM),
(H) (OVX + Oryzanol).
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gically important processes in plants, such as response to
biotic and abiotic stresses, defence against herbivores, ac-
tivation of phytohormones, lignification and cell-wall
remodelling [47]. Despite the fact that the different com-
pounds give almost the same gross effects in terms of re-
storing the measured anatomical indices of the uterus,cytological evidences showed variability in distribution of
leucocytes and epithelial and cornified cells across the
treatment groups(Table 2). Likewise, the histological ap-
pearance of the various cells in the groups showed diffe-
rent configurations in term of glands, epithelial lining and
activity (Figure 2). Furthermore, the PCNA reaction ob-
served within the various treatment groups varied in the
Figure 3 Immunohistochemical staining of PCNA showing specific sites of binding on the nuclei in the luminal, glandular epithelium
and stromal cells of oopherectomised rat uteri treated with the different fractions of the compounds for 8 weeks. LE = PCNA positive
cells staining at the luminal epithelial cells; S = PCNA positive cells staining ofthe stromal cells; GE = PCNA positive cells staining at the glandular
epithelial cells cells. (A) Sham operated (No OVX), (B) OVX (No treatment), (C) oestrogen treated (OVX + EST), (D) ASG fraction (OVX + ASG),
(E) GABA fraction (OVX + GABA), (F) GBR fraction (OVX + GBR), (G) Remifemin treated (OVX + REM), (H) (OVX + Oryzanol).
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result of different molecular mechanisms of action, which
need to be ascertained in further studies.
Conclusion
The uterine modulatory effects of GBR and its bioactives
observed in this study might be due to the antioxidant
and anti-inflammatory effects of its various components.Studies are also underway to determine whether GBR
has oestrogen receptor binding activity and other effects
relating to mechanisms of the utero-trophic modulations
of GBR in menopause.
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